Skip to main content
Frontiers in Nutrition logoLink to Frontiers in Nutrition
. 2021 Aug 24;8:690663. doi: 10.3389/fnut.2021.690663

Dietary Risk-Related Colorectal Cancer Burden: Estimates From 1990 to 2019

Yujiao Deng 1,2,, Bajin Wei 1,3,, Zhen Zhai 1,2,, Yi Zheng 1,2, Jia Yao 1, Shuqian Wang 1, Dong Xiang 4, Jingjing Hu 5, Xianghua Ye 6, Si Yang 1,2, Ying Wu 1,2, Na Li 1,2, Peng Xu 2, Jun Lyu 7,*, Zhijun Dai 1,2,*
PMCID: PMC8421520  PMID: 34504859

Abstract

Background: Colorectal cancer remains a public health problem worldwide. Dietary risk factors play a key role in the carcinogenesis and progression of colorectal cancer. This study aimed to explore the geographical and temporal trends in various dietary factor-related colorectal cancers.

Methods: Data were extracted from the Global Burden of Disease (GBD) 2019 study, including the deaths, disability-adjusted life-years (DALYs), age-standardized rate (ASR), and summary exposure value (SEV) among 4 world regions, 11 age groups, 21 regions, and 204 countries and territories between 1990 and 2019. The estimated annual percentage changes (EAPCs) were calculated to evaluate the variation trend of ASR.

Results: Dietary factors were the leading cause of colorectal cancer death and DALY rate, regardless of age. Dietary factor-related deaths and DALYs accounted for 32 and 34% of global colorectal cancer, respectively. Further analysis showed that low whole grain intake remained the leading cause of cancer death and DALY rate, followed by milk and calcium. Diets that were low in whole grains, milk, and calcium accounted for 81.61% of deaths and 81.64% of DALYs. Deaths and DALYs of dietary factors related to colorectal cancer grew by half from 1990 to 2019. All ASRs remained higher for men than women. Asia carried the highest colorectal cancer burden attributed to dietary risks, especially for East Asia [age-standardized death rate (ASDR): EAPC = 1.15, 95% CI:0.88–1.42; DALY: EAPC = 1.08, 95% CI:0.82–1.34]. The heavy burden also existed in high-middle and middle socio-demographic index (SDI) quintiles. China has always had the highest deaths and DALYs of colorectal cancer attributable to dietary risks, followed by the USA, India, and Japan.

Conclusions: Large variations existed in the dietary risk-related colorectal cancer burdens among sexes, regions, and countries. More targeted interventions to address modifiable dietary risk factors would save 32% of deaths and 34% of DALYs for colorectal cancer.

Keywords: colorectal cancer, nutrient, dietary risk, death, disability-adjusted life- years

Introduction

In 2019, colorectal cancer accounted for more than 24.28 million disability-adjusted life-years (DALYs) and 1.15 million deaths worldwide (1). It was also the second leading cause of cancer deaths. Modifiable risk factors, such as environmental, behavioral, and metabolic risks, played a key role in the carcinogenesis and progression of colorectal cancer, which are potentially preventable (2). Epidemiological and experimental investigations have also demonstrated an association between nutritional intake and the risk of colorectal cancer. Calcium, fiber, milk, and whole grains might reduce this risk, while red and processed meats increased the risk (3). Furthermore, diet can influence the development of colorectal cancer through a variety of interaction mechanisms, including influences on immune reactivity, inflammation, and intestinal microbiota (4). In 2019, dietary factors were the second leading cause of death in women (3.48 million deaths) and the third leading cause of death in men (4.47 million deaths) (2). It was reported that 47% of colorectal cancer cases in the USA and 45% in the UK were attributable to modifiable risk factors (5, 6). However, the distribution of these risk factors varies in different countries and regions, with the influence degree of the same risk factor on the population of different regions and genders being different. Cancer-specific reports support more detailed explorations and provide useful information for colorectal cancer prevention, treatment, and management (7).

The Global Burden of Disease (GBD) 2019 study carried a broad array of data sources and scientific statistical modeling approaches and included up-to-date data of 369 diseases and injuries and their 87 related risk factors globally (8). Therefore, this systematic investigation of dietary consumption patterns of colorectal patients was conducted to provide a comprehensive illustration of prognostic effects of unhealthy dietary habits at the global level.

Materials and Methods

Data Sources

Dietary factor-related colorectal cancer deaths and DALY data were collected by the GBD 2019 study using Global Heath Data Exchange Tool (http://ghdx.healthdata.org/). Deaths, DALYs, age-standardized rates (ASRs), summary exposure values (SEV), and annualized rates of change (ARC, %) and their 95% uncertainty intervals (UIs) from 1990 to 2019 among 4 world regions, 5 socio-demographic index (SDI) quintiles, 21 regions, and 204 countries and territories were extracted. The SDI, ranging from 0 to 1, is a comprehensive measure of development and is an indicator of the overall fertility rate, educational attainment, and lagging per capita income distribution in a country. Based on SDI values in 2019, countries and territories were classified into five categories (high, high-middle, middle, low-middle, and low). All the rates were reported per 100,000 persons. The analysis of this study is in accordance with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) (Appendix 1). Detailed data descriptions and search strategies are presented in Appendix 2.

Exposure Definition

Six dietary risk factors were evaluated in this analysis, including diets low in fiber, high in processed meat, high in red meat, low in calcium, low in milk, and low in whole grains. Diets low in whole grains represent an average daily consumption (in g per day) of less than 140–160 g of whole grains (germ, endosperm, and bran in the natural proportion) from biscuits, pancakes, bread, breakfast cereals, tortillas, rice, muffins, pasta, and other sources. Diets low in milk represent an average daily intake (in grams per day) of less than 360–500 g of milk including full-fat, low-fat, and non-fat milk, excluding soy milk and other plant derivatives. Diets high in red meat represent any intake (in g per day) of red meat including lamb, pork, beef, and goat but excluding eggs, fish, poultry, and all processed meats. Diets high in processed meat represent any intake (in g per day) of meat preserved by curing, smoking, salting, or addition of chemical preservatives. Diets low in fiber represent an average daily consumption (in g per day) of less than 21–22 g of fiber from all sources including grains, fruits, pulses, vegetables, and legumes. Diets low in calcium represent an average daily consumption (in g per day) of less than 1.06–1.1 g of calcium from all sources, including cheese, milk, and yogurt.

Measures Estimation

The ASR is a measure that can eliminate the influence of population age structure difference to the greatest extent, which was calculated based on the world standard population. The ASR was calculated based on the following formula:

ASR=i=1Aaiwii=1Awi×100,000

The ASR (per 100,000 population) is equal to the sum of the product of the specific age ratio (ai) in age group i and the number (or weight) (wi) of the selected reference standard population group i divided by the sum of the number (or weight) of the standard population (i.e., the weight is derived from the GBD 2019 world standard population rather than the global population size in 2019).

Meanwhile, the estimated annual percentage changes (EAPC) were calculated to evaluate the variation trend of ASR based on our previous methods (9). The EAPC, which is approximately equal to the annual change over a specified time period, was calculated using the following regression model to assess the trends in ASR: Y = α + βx + ε, where y refers to ln (ASR), x represents calendar year, ε means error term, and β determines the positive or negative trends in ASR.

The EAPC is calculated as 100 * [exp (β) – 1]. Its 95% CI can be obtained from the linear regression model. If both the EAPC estimates and their lower limits of 95% CIs are more than 0, ASR is in an upward trend. In contrast, if both EAPC estimates and their upper limits of 95% CIs are less than 0, ASR is in a downward trend. Otherwise, ASR is stable.

Statistical Analysis

The GBD 2019 study used SEV to summarize the exposure distribution of dichotomous, multi-categorical, and continuous risk factors. The summary exposure value is a univariate measure of risk-weighted exposure with a range from 0 to 100%, which is 0 when the population is at no additional risk and 1 when the population is at the highest risk level. A decrease in SEV indicates a decrease in exposure to a particular risk factor, while an increase in SEV indicates an increase in exposure. DALYs were estimated by summing up the years lived with disability (YLDs) and years of life lost (YLLs). Four sequelae including diagnosis or treatment, remission, metastatic disseminate, and terminal phase were used to estimate YLDs. Then, YLDs were calculated by each sequela prevalence multiplied by a disability weight. The YLLs were estimated by multiplying the number of deaths in the age of patients with the standard life expectancy for that age. Data were presented as values with a 95% CI or 95% UI. The main analysis tools covered the Spatiotemporal Gaussian Process Regression and Dismod-MR 2.1. All tests and calculations were conducted by the R program (version 3.7.0).

Results

Summary Exposure Value and Risk-Specific Trends

The age-standardized SEV rate of dietary risks among humans decreased globally (ARC = −0.08, 95% UI: −0.14 to 0.04), from 51.31 (95% UI: 40.44−62.42) in 1990 to 47.1 per 100,000 persons (95% UI: 35.39−59.62) in 2019. At the regional level, East Asia has always had the highest age-standardized SEV rate (80.99 in 1990 and 76.33 in 2019), followed by Central Europe and the high-income Asia Pacific (Table 1). It increased the fastest in high-income North America (ARC = 0.15, 95% UI: 0.03–0.3) but decreased the fastest in high-income Asia Pacific (ARC = −0.28, 95% UI: −0.42 to 0.17). In addition, the SDI quintile with the highest age-standardized SEV rate changed from middle SDI (ASR = 59.93, 95% UI: 49.6–68.46) into high-middle SDI (ASR = 55.03, 95% UI: 44.56–64.09), while it remained the lowest in the low SDI quintile. China carried the highest age-standardized SEV rate of dietary risk in 2019 (77.37, 69.58–81.93), especially for women. As for men, Hungary had the top exposure (82.2, 73.79–87.31, Supplementary Table 1).

Table 1.

Age-standardized summary exposure value rates of dietary risks related to colorectal cancer and annualized rate of changes.

Location Sex Age-standardized SEV rate (95% UI) ARC (%) (95% UI)
1990 2019 1990–2010 2010–2019 1990–2019
Global Both 51.31 (40.44–62.42) 47.1 (35.39–59.62) −0.06 (−0.1–0.03) −0.02 (−0.04–0.01) −0.08 (−0.14–0.04)
Female 48.52 (38.08–60.29) 43.53 (32.43–56.78) −0.08 (−0.12–0.04) −0.03 (−0.05–0.01) −0.1 (−0.16–0.05)
Male 54.21 (43.11–64.75) 50.78 (38.2–62.65) −0.04 (−0.09–0.02) −0.02 (−0.04–0.01) −0.06 (−0.12–0.03)
Sociodemographic Index
High SDI Both 43.59 (33.19–55.53) 41.11 (28.52–54.36) −0.05 (−0.13–0) −0.01 (−0.03–0.01) −0.06 (−0.15–0)
Female 40.93 (31.33–53.31) 36.13 (26.05–49.54) −0.11 (−0.17–0.05) −0.01 (−0.03–0.01) −0.12 (−0.19–−0.05)
Male 46.36 (35.27–57.83) 46 (30.89–59.21) 0 (−0.11–0.07) −0.01 (−0.04–0.02) −0.01 (−0.13–0.06)
High–middle SDI Both 56.53 (46.59–65.64) 55.03 (44.56–64.09) −0.03 (−0.06–0.01) 0 (−0.01–0.02) −0.03 (−0.06–0)
Female 51.96 (42.75–61.87) 50.18 (40.43–60.01) −0.04 (−0.07–0.01) 0 (−0.02–0.02) −0.03 (−0.08–0)
Male 61.49 (50.72–69.89) 60.06 (49.12–68.54) −0.03 (−0.06–0) 0 (−0.01–0.02) −0.02 (−0.06–0.01)
Low SDI Both 37.34 (23.04–59.49) 35.02 (22.2–57.69) −0.05 (−0.11–0) −0.01 (−0.03–0) −0.06 (−0.13–0.01)
Female 37.44 (22.61–59.8) 34.8 (21.63–58.65) −0.06 (−0.13–0.01) −0.01 (−0.03–0.01) −0.07 (−0.15–0.01)
Male 37.24 (23.14–59.09) 35.26 (22.87–56.95) −0.04 (−0.1–0.02) −0.01 (−0.04–0.02) −0.05 (−0.12–0.02)
Low–middle SDI Both 44.59 (32.17–58.16) 42.49 (28.81–57.02) −0.01 (−0.05–0.01) −0.04 (−0.07–0.01) −0.05 (−0.11–0.01)
Female 42.55 (30.37–56.98) 39.15 (26.12–55.07) −0.03 (−0.07–0.01) −0.05 (−0.1–0.01) −0.08 (−0.15–0.03)
Male 46.55 (33.84–59.44) 45.91 (31.67–59.41) 0.01 (−0.04–0.04) −0.02 (−0.05–0) −0.01 (−0.07–0.02)
Middle SDI Both 59.93 (49.6–68.46) 51.28 (39.84–61.83) −0.11 (−0.16–0.07) −0.04 (−0.06–0.02) −0.14 (−0.21–0.09)
Female 57.31 (46.72–66.69) 48.15 (36.93–59.31) −0.12 (−0.18–0.08) −0.04 (−0.07–0.02) −0.16 (−0.23–0.1)
Male 62.56 (52.55–70.53) 54.52 (42.45–64.62) −0.1 (−0.15–0.05) −0.04 (−0.07–0.01) −0.13 (−0.2–0.07)
Region
Andean Latin America Both 34.85 (20.33–50.29) 33.57 (19.65–49) −0.04 (−0.11–0.03) 0 (−0.05–0.04) −0.04 (−0.13–0.04)
Female 30.66 (18.96–46.79) 28.67 (17.36–43.96) −0.06 (−0.14–0.01) −0.01 (−0.06–0.04) −0.06 (−0.16–0.01)
Male 39.19 (21.36–54.5) 38.69 (20.97–54.56) −0.02 (−0.13–0.09) 0.01 (−0.06–0.08) −0.01 (−0.15–0.12)
Australasia Both 37.52 (27.78–51) 36.01 (26.13–50.6) −0.04 (−0.13–0.03) 0 (−0.05–0.04) −0.04 (−0.14–0.04)
Female 32.83 (25.18–45.45) 31.92 (23.79–45.38) −0.02 (−0.08–0.05) −0.01 (−0.05–0.04) −0.03 (−0.1–0.06)
Male 42.22 (28.54–57.53) 40.26 (26.54–56.91) −0.05 (−0.18–0.07) 0 (−0.08–0.08) −0.05 (−0.2–0.1)
Caribbean Both 25.66 (16.87–39.73) 24.11 (15.38–38.5) −0.07 (−0.12–0.02) 0.01 (−0.02–0.04) −0.06 (−0.12–0)
Female 23.09 (15.35–36.12) 21.4 (13.96–34.93) −0.08 (−0.12–0.02) 0 (−0.03–0.04) −0.07 (−0.13–0)
Male 28.39 (17.38–43.83) 26.99 (15.74–42.52) −0.06 (−0.13–0.01) 0.01 (−0.03–0.06) −0.05 (−0.13–0.04)
Central Asia Both 52.7 (39.2–65.64) 39.09 (25.51–54.89) −0.25 (−0.35–0.15) −0.02 (−0.05–0.02) −0.26 (−0.37–0.16)
Female 43.02 (29.72–58.75) 31.31 (21.09–46.88) −0.26 (−0.36–0.17) −0.02 (−0.05–0.01) −0.27 (−0.38–0.18)
Male 63.58 (49.64–74.23) 47.6 (29.71–63.67) −0.24 (−0.41–0.13) −0.01 (−0.07–0.03) −0.25 (−0.43–0.13)
Central Europe Both 67.6 (56–75.98) 59.85 (44.49–71.19) −0.1 (−0.2–0.04) −0.01 (−0.04–0) −0.11 (−0.22–0.05)
Female 59.12 (44.86–71.08) 46.08 (27.5–62.54) −0.19 (−0.35–0.08) −0.04 (−0.08–0.01) −0.22 (−0.39–0.1)
Male 76.48 (67.73–81.72) 74.02 (61.69–81.05) −0.03 (−0.11–0.01) 0 (−0.03–0.03) −0.03 (−0.11–0.01)
Central Latin America Both 40.57 (25.34–55.43) 40.17 (25.06–55.13) 0.01 (−0.04–0.1) −0.02 (−0.08–0.02) −0.01 (−0.07–0.06)
Female 34.81 (20.25–50.86) 34.23 (19.85–50.49) 0.04 (−0.05–0.17) −0.05 (−0.16–0.02) −0.02 (−0.09–0.06)
Male 46.68 (30.43–60.42) 46.83 (30.35–60.67) 0 (−0.08–0.08) 0.01 (−0.04–0.06) 0 (−0.08–0.11)
Central Sub–Saharan Africa Both 26.55 (17.71–48.61) 28.18 (18.82–52.39) 0.08 (−0.01–0.17) −0.01 (−0.07–0.04) 0.06 (−0.03–0.17)
Female 26.09 (17.37–47.7) 28.18 (18.8–51.84) 0.09 (−0.03–0.21) −0.01 (−0.1–0.06) 0.08 (−0.05–0.22)
Male 27.04 (17.75–49.98) 28.21 (18.75–52.7) 0.06 (−0.06–0.18) −0.02 (−0.08–0.05) 0.04 (−0.08–0.18)
East Asia Both 80.99 (74.41–84.33) 76.33 (68.25–81.08) −0.05 (−0.08–0.01) −0.01 (−0.03–0) −0.06 (−0.1–0.02)
Female 79.15 (71.96–83.25) 74 (64.71–79.75) −0.05 (−0.11–0.01) −0.02 (−0.05–0.01) −0.07 (−0.13–0.02)
Male 82.96 (76.74–86.27) 78.78 (71.59–83.12) −0.04 (−0.08–0.01) −0.01 (−0.03–0.01) −0.05 (−0.09–0.01)
Eastern Europe Both 43.15 (30.05–58.2) 39.79 (26.46–55.74) −0.08 (−0.16–0.01) 0 (−0.05–0.04) −0.08 (−0.18–0)
Female 37.28 (26.46–52.94) 33.83 (22.53–50.22) −0.09 (−0.18–0.02) 0 (−0.06–0.05) −0.09 (−0.2–0)
Male 50.21 (33.45–66.06) 46.78 (30.02–63.07) −0.07 (−0.18–0.04) 0 (−0.07–0.07) −0.07 (−0.2–0.06)
Eastern Sub–Saharan Africa Both 46.86 (24.44–75.94) 36.02 (20.74–65.92) −0.21 (−0.33–0.09) −0.02 (−0.05–0.01) −0.23 (−0.35–0.1)
Female 49.79 (24.05–80.2) 40.23 (20.7–74.68) −0.19 (−0.32–0.06) 0 (−0.04–0.02) −0.19 (−0.32–0.07)
Male 43.75 (24.71–71.33) 31.58 (20.38–57.02) −0.24 (−0.36–0.09) −0.05 (−0.1–0.02) −0.28 (−0.41–0.1)
High–income Asia Pacific Both 66.23 (53.14–74.48) 48 (31.29–61.12) −0.25 (−0.39–0.15) −0.03 (−0.07–0) −0.28 (−0.42–0.17)
Female 61.7 (46.29–72.14) 42.07 (25.57–56.85) −0.29 (−0.44–0.18) −0.03 (−0.08–0.01) −0.32 (−0.47–0.2)
Male 70.97 (59.42–77.39) 53.83 (36.51–66.01) −0.21 (−0.37–0.12) −0.04 (−0.09–0.01) −0.24 (−0.4–0.13)
High–income North America Both 34.19 (24.34–48.18) 39.48 (26.2–53.68) 0.16 (0.04–0.29) −0.01 (−0.05–0.04) 0.15 (0.03–0.3)
Female 34.64 (24.21–49.58) 34.06 (23.53–48.92) −0.02 (−0.08–0.06) 0 (−0.05–0.05) −0.02 (−0.1–0.08)
Male 33.76 (24.58–46.87) 45.08 (28.34–59.42) 0.35 (0.11–0.57) −0.01 (−0.08–0.05) 0.34 (0.09–0.57)
North Africa and Middle East Both 20.72 (14.91–30.26) 19.53 (13.84–29.24) −0.07 (−0.12–0.04) 0.02 (−0.01–0.04) −0.06 (−0.11–0.01)
Female 19.45(14.45–26.62) 17.75(13.09–24.64) −0.1(−0.15–0.05) 0.01(−0.03–0.06) −0.09(−0.14–0.04)
Male 21.92(14.5–34.32) 21.15(13.61–33.87) −0.05(−0.11–0) 0.02(−0.01–0.05) −0.04(−0.1–0.03)
Oceania Both 30.66(24.11–40.92) 30.95(22.03–43.22) 0.02(−0.08–0.1) −0.01(−0.06–0.03) 0.01(−0.11–0.1)
Female 29.16(22.47–39.62) 29.2(20.74–42.23) 0.01(−0.1–0.11) −0.01(−0.06–0.04) 0(−0.13–0.12)
Male 32.11(25.29–42.1) 32.59(23.11–44.73) 0.03(−0.09–0.13) −0.01(−0.08–0.05) 0.02(−0.13–0.13)
South Asia Both 39.71(26.36–54.17) 40.5(25.87–54.9) 0.04(0–0.08) −0.02(−0.04–0) 0.02(−0.04–0.06)
Female 38.84(25.83–54.13) 36.77(23.47–52.52) −0.01(−0.05–0.02) −0.04(−0.08–0.01) −0.05(−0.11–0.01)
Male 40.51(26.81–54.63) 44.17(28.35–57.92) 0.09(0.04–0.16) 0(−0.02–0.02) 0.09(0.03–0.16)
Southeast Asia Both 58.55(42.01–69.9) 45.37(27.48–60.3) −0.18(−0.3–0.1) −0.05(−0.11–0.02) −0.23(−0.36–0.13)
Female 54.6(36.02–68.21) 41.71(23.8–58.31) −0.2(−0.33–0.11) −0.05(−0.11–0.01) −0.24(−0.38–0.13)
Male 62.86(47.66–72.66) 49.37(31.39–62.91) −0.17(−0.29–0.08) −0.06(−0.12–0.02) −0.21(−0.36–0.12)
Southern Latin America Both 43.77(29.56–58.37) 40.91(26.41–56.1) −0.07(−0.15–0.01) 0(−0.04–0.05) −0.07(−0.16–0.01)
Female 39.33(27.31–54.71) 35.97(24.23–52.03) −0.08(−0.16–0) −0.01(−0.06–0.03) −0.09(−0.18–0.01)
Male 48.51(31.25–63.07) 46.18(28–60.93) −0.06(−0.17–0.03) 0.02(−0.05–0.09) −0.05(−0.17–0.07)
Southern Sub–Saharan Africa Both 40.07(23.86–70.07) 36.12(23.76–64.14) −0.1(−0.2–0.03) 0(−0.04–0.04) −0.1(−0.21–0.04)
Female 38.44(23.49–69.9) 35.77(23.48–64.94) −0.07(−0.18–0.04) 0(−0.05–0.05) −0.07(−0.19–0.05)
Male 41.83(24.08–70.97) 36.47(23.83–63.53) −0.12(−0.26–0.03) −0.01(−0.07–0.06) −0.13(−0.27–0.04)
Tropical Latin America Both 39.61(24.74–55.19) 39.26(25.4–53.72) −0.02(−0.11–0.1) 0.01(−0.04–0.07) −0.01(−0.11–0.13)
Female 35.99(23.24–52.14) 35.61(24.65–50.05) −0.03(−0.13–0.08) 0.01(−0.04–0.08) −0.01(−0.13–0.12)
Male 43.47(25.11–59.45) 43.23(25.38–59.13) −0.01(−0.15–0.17) 0(−0.09–0.1) −0.01(−0.16–0.19)
Western Europe Both 36.27(25.75–50.06) 37.97(25.95–52.05) 0.01(−0.03–0.05) 0.03(0–0.06) 0.05(−0.02–0.1)
Female 31.42(23.33–44.81) 31.91(22.9–45.72) −0.01(−0.04–0.04) 0.02(−0.01–0.06) 0.02(−0.04–0.08)
Male 41.29(27.23–56.2) 44.1(28.37–59.18) 0.03(−0.04–0.09) 0.04(0–0.09) 0.07(−0.01–0.15)
Western Sub–Saharan Africa Both 30.54(18.61–59.9) 30.01(17.41–60.69) −0.02(−0.08–0.04) 0(−0.03–0.04) −0.02(−0.09–0.05)
Female 30.09(18.45–59.04) 29.58(17.24–60.32) −0.02(−0.08–0.05) 0(−0.03–0.04) −0.02(−0.09–0.07)
Male 30.96 (18.6–60.85) 30.48(17.53–60.57) −0.02(−0.1–0.05) 0.01(−0.03–0.05) −0.02(−0.11–0.08)

ARC, annualized rate of change; SEV, summary exposure value; SDI, socio–demographic index; UI, uncertainty interval.

Further analysis showed that age-standardized SEV rate increased for diets high in red meat (ARC = 0.09, 95% UI: 0.04–0.15, Supplementary Table 2) and low in milk (ARC = 0.03, 95% UI: 0.01–0.05, Supplementary Table 3). It decreased for diets low in calcium (ARC = −13, 95%UI: −0.06 to 0.18, Supplementary Table 4), whole grains (ARC = −0.01, 95% UI: −0.02 to 0.01, Supplementary Table 5), and fiber (ARC = −0.25, 95% UI: −0.21 to 0.3, Supplementary Table 6); it was kept stable for diets high in processed meat (ARC = −0.04, 95% UI: −0.11 to 0.04, Supplementary Table 7) for over 30 years globally.

Global Attributable Burden

In 2019, an estimated 1 million people died from colorectal cancer, with 24 million DALYs. Dietary risk-related deaths and DALYs accounted for 32 and 34%, respectively (Tables 2, 3). The dietary risk was the primary factor of colorectal cancer death and DALY rate (Supplementary Figure 1).

Table 2.

Deaths, ASDRs, and change trends of colorectal cancer attributable to dietary risks between 1990 and 2019.

Location Sex Deaths (95% UI) ASDR (95% UI) EAPC (95% CI)
1990 2019 1990 2019 1990–2019
Global Both 179639.2 (138268.4–212910.39) 365751.8 (272831.26–442144.29) 4.95 (3.82–5.88) 4.61 (3.43–5.58) −0.29 (−0.36–0.22)
Female 88528.61 (66627.46–105332.68) 161411.62 (118853.46–195783.1) 4.38 (3.3–5.24) 3.69 (2.72–4.47) −0.7 (−0.77–0.62)
Male 91110.58 (70612.93–107476.18) 204340.18 (152123.06–246151.48) 5.72 (4.43–6.73) 5.71 (4.26–6.91) 0.02 (−0.06–0.09)
Sociodemographic Index
High SDI Both 71931.18 (53299.33–88470.24) 105343.32 (76587.92–129173.68) 6.86 (5.09–8.43) 5.25 (3.83–6.41) −1.04 (−1.11–0.98)
Female 35679.85 (26077.35–44361.13) 48754.24 (35264.31–60676.94) 5.64 (4.12–6.98) 4.16 (3.01–5.13) −1.19 (−1.28–1.11)
Male 36251.34 (26897.69–44027.87) 56589.08 (41323.31–68668.46) 8.63 (6.42–10.51) 6.57 (4.8–7.96) −1.06 (−1.11–1.01)
High–middle SDI Both 57246.81 (42913.76–67889.67) 107585.91 (78263.39–131416.46) 5.66 (4.23–6.74) 5.35 (3.89–6.53) −0.32 (−0.43–0.2)
Female 28794.62 (21443.6–34485.75) 46426.25 (32897.5–57824.06) 4.89 (3.64–5.87) 4.04 (2.87–5.04) −0.86 (−0.98–0.75)
Male 28452.2 (21775.27–33706.01) 61159.65 (44589.53–75189.32) 6.85 (5.25–8.14) 7.11 (5.2–8.73) 0.09 (−0.04–0.22)
Low SDI Both 5264.04 (4117.79–6470.27) 13113.09 (10344.37–15521.27) 2.47 (1.93–3.02) 2.8 (2.21–3.3) 0.44 (0.39–0.49)
Female 2338.87 (1736.23–3084.6) 6206.81 (4830.83–7385.71) 2.21 (1.63–2.9) 2.58 (2.01–3.07) 0.55 (0.48–0.61)
Male 2925.17 (2244.06–3850.34) 6906.28 (5339.58–8350.87) 2.73 (2.1–3.53) 3.04 (2.37–3.68) 0.38 (0.35–0.42)
Low–middle SDI Both 13449.7 (10850.92–16002.52) 40684.34 (31497.84–48680.66) 2.48 (2.01–2.94) 3.2 (2.48–3.82) 0.89 (0.84–0.94)
Female 6447.99 (5085.01–7836.74) 19306.24 (14853.87–23540.99) 2.39 (1.9–2.88) 2.89 (2.24–3.52) 0.62 (0.56–0.69)
Male 7001.72 (5563.84–8797.55) 21378.09 (16386.79–25630.82) 2.56 (2.04–3.22) 3.53 (2.72–4.23) 1.16 (1.09–1.23)
Middle SDI Both 31651.65 (25701.02–36920.12) 98820.99 (75848.49–119915.13) 3.36 (2.74–3.91) 4.22 (3.25–5.11) 0.96 (0.81–1.11)
Female 15219.18 (12170.79–18040.02) 40621.79 (30883.32–50020.19) 3.11 (2.5–3.67) 3.3 (2.52–4.05) 0.27 (0.16–0.37)
Male 16432.46 (13332.68–19480.45) 58199.2 (44331.31–71174.35) 3.64 (2.95–4.28) 5.28 (4.02–6.44) 1.54 (1.36–1.73)
Region
Africa Both 7057.68 (5597.92–8465.32) 17607.01 (13630.99–21016.94) 2.76 (2.19–3.3) 3.14 (2.44–3.73) 0.46 (0.42–0.51)
Female 3308.55 (2582.86–4085.68) 8296.95 (6369.81–10076.31) 2.56 (1.98–3.13) 2.87 (2.21–3.48) 0.45 (0.4–0.51)
Male 3749.13 (2967.26–4643.35) 9310.06 (7088.87–11151.48) 2.96 (2.34–3.63) 3.43 (2.63–4.09) 0.49 (0.45–0.54)
America Both 33094.61 (24599.76–40381.23) 57120.16 (41832.33–70031.24) 5.51 (4.1–6.72) 4.44 (3.25–5.43) −0.81 (−0.87–0.75)
Female 16558.45 (12159.37–20279.28) 27272.61 (19781.77–33906.3) 4.79 (3.52–5.87) 3.78 (2.74–4.69) −0.87 (−0.92–0.82)
Male 16536.16 (12468.35–19938.51) 29847.54 (22140.67–36246.84) 6.43 (4.85–7.78) 5.22 (3.87–6.34) −0.8 (−0.89–0.72)
Asia Both 66786.92 (53102.08–77966.39) 195145.69 (147389.53–237221.87) 3.69 (2.93–4.31) 4.34 (3.29–5.28) 0.69 (0.55–0.83)
Female 31144.97 (24484.32–37202.32) 81357.75 (61820.49–99481) 3.31 (2.6–3.95) 3.39 (2.58–4.15) 0.12 (0.02–0.22)
Male 35641.95 (28058.24–42167.98) 113787.94 (85312.35–139420.85) 4.15 (3.27–4.87) 5.43 (4.12–6.66) 1.14 (0.97–1.32)
Europe Both 72433.43 (88178.21–53156.58) 95298.3 (117189.59–67409.52) 7.03 (8.56–5.17) 5.87 (7.2–4.15) −0.88 (−1.03–0.74)
Female 37391.5 (45831.54–27002.24) 44218.97 (54941.5–30946.54) 5.88 (7.18–4.24) 4.54 (5.64–3.18) −1.19 (−1.35–1.04)
Male 35041.93 (42349.64–25992.69) 51079.33 (62990.88–36812.99) 8.94 (10.82–6.63) 7.71 (9.5–5.57) −0.73 (−0.87–0.6)
Andean Latin America Both 564.24 (449.13–676.29) 1897.82 (1352.58–2444.07) 2.95 (2.35–3.53) 3.48(2.48–4.49) 0.74 (0.6–0.88)
Female 301.53 (237.13–362.13) 1006.72 (721.1–1301.36) 3.08 (2.43–3.7) 3.51 (2.52–4.54) 0.49 (0.35–0.62)
Male 262.71 (207.71–319.13) 891.1 (639.38–1158.97) 2.8 (2.2–3.4) 3.43 (2.47–4.46) 1.04 (0.87–1.2)
Australasia Both 1963.87 (1469.98–2384.69) 2953.68 (2192.44–3624.15) 8.5 (6.37–10.32) 5.74 (4.3–7.02) −1.66 (−1.78–1.54)
Female 932.18 (695.03–1138.53) 1362.7 (989.48–1696.88) 7.13 (5.3–8.72) 4.78 (3.51–5.91) −1.63 (−1.74–1.53)
Male 1031.68 (780.38–1245.66) 1590.98 (1199.44–1940.77) 10.28 (7.8–12.44) 6.83 (5.17–8.33) −1.77 (−1.92–1.62)
Caribbean Both 1110.65 (825.56–1321.26) 2501.5 (1734.12–3168.48) 4.45 (3.31–5.3) 4.84 (3.36–6.13) 0.25 (0.18–0.31)
Female 570.44 (420.32–686.58) 1257.44 (861.55–1620.59) 4.38 (3.23–5.27) 4.47 (3.06–5.78) 0.01 (−0.05–0.07)
Male 540.21 (403.17–641.78) 1244.06 (874.67–1584.35) 4.51 (3.37–5.36) 5.24 (3.7–6.66) 0.49 (0.41–0.58)
Central Asia Both 1893.23 (1415.75–2257.29) 2609.51 (1914.55–3145.16) 4.07 (3.04–4.86) 3.91 (2.87–4.72) 0 (−0.12–0.13)
Female 966.66 (712.59–1165.02) 1270.05 (920.45–1545.39) 3.52 (2.6–4.24) 3.34 (2.41–4.04) −0.06 (−0.17–0.04)
Male 926.57 (697.11–1095.76) 1339.47 (975.47–1624.49) 4.9 (3.7–5.8) 4.73 (3.4–5.71) 0.03 (−0.13–0.19)
Central Europe Both 9515.82 (6655.97–11758.29) 15606.71 (10535.6–19884.82) 6.65 (4.65–8.23) 7.15 (4.84–9.09) 0.27 (0.15–0.38)
Female 4448.42 (3053.54–5556.24) 6572.32 (4380.02–8479.17) 5.35 (3.68–6.69) 5.08 (3.35–6.58) −0.24 (−0.35–−0.13)
Male 5067.4 (3614.83–6250.35) 9034.4 (6186.29–11468.54) 8.5 (6.04–10.45) 10.03 (6.86–12.67) 0.67 (0.54–0.81)
Central Latin America Both 1895.34 (1455.16–2277.69) 7018.48 (4940.31–8988.84) 2.44 (1.88–2.94) 3.04 (2.14–3.89) 0.73 (0.69–0.78)
Female 998.35 (757.79–1213.54) 3394.03 (2377.59–4411.01) 2.5 (1.9–3.05) 2.71 (1.9–3.52) 0.26 (0.2–0.32)
Male 897 (696.44–1063.87) 3624.45 (2556.47–4628.27) 2.37 (1.85–2.81) 3.42 (2.41–4.35) 1.23 (1.18–1.29)
Central Sub–Saharan Africa Both 590.72 (446.83–758.46) 1402.16 (1017.61–1854.24) 2.98 (2.24–3.83) 2.97 (2.14–4.03) −0.1 (−0.32–0.13)
Female 260.33 (187.57–348.34) 663.51 (471.92–926.22) 2.5 (1.85–3.28) 2.54 (1.78–3.62) 0 (−0.19–0.19)
Male 330.39 (243.36–451.32) 738.65 (516.69–1117.78) 3.51 (2.52–4.95) 3.57 (2.49–5.63) −0.06 (−0.3–0.17)
East Asia Both 31018.09 (24136.55–36894.33) 95245.6 (69351.49–119482) 3.86 (3.03–4.6) 4.85 (3.55–6.08) 1.15 (0.88–1.42)
Female 14332.81 (10968.01–17683.65) 34563.28 (24432.75–45048.48) 3.4 (2.59–4.18) 3.31 (2.34–4.3) −0.08 (−0.14–0.29)
Male 16685.28 (12751.75–20675.21) 60682.32 (43189.63–79278.65) 4.54 (3.52–5.55) 6.85 (4.93–8.9) 1.94 (1.64–2.24)
Eastern Europe Both 17925.21 (13334.61–21587.66) 19858.25 (13870.79–25211.21) 6.47 (4.83–7.8) 5.72 (4–7.27) −1.02 (−1.29–0.76)
Female 10177.61 (7492.29–12362.98) 10291.51 (7009.14–13367.37) 5.59 (4.13–6.79) 4.61 (3.12–6) −1.26 (−1.5–1.02)
Male 7747.6 (5807.9–9311.99) 9566.73 (6670.42–12252.84) 8.42 (6.33–10.12) 7.71 (5.4–9.84) −0.93 (−1.22–0.63)
Eastern Sub–Saharan Africa Both 1877.58 (1469.8–2329.76) 4653.33 (3528.04–5752.95) 2.71 (2.13–3.34) 3.13 (2.4–3.85) 0.5 (0.44–0.56)
Female 843.25 (609.76–1121.49) 2176.25 (1651.36–2723.77) 2.39 (1.75–3.14) 2.77 (2.11–3.42) 0.54 (0.46–0.61)
Male 1034.32 (778.49–1410.05) 2477.08 (1840.74–3220.05) 3.06 (2.33–4.01) 3.55 (2.69–4.58) 0.52 (0.47–0.57)
High–income Asia Pacific Both 10886.35(7944.54–13313.66) 25261.76 (18175.96–31455.85) 5.68 (4.16–6.92) 5.04 (3.64–6.2) −0.42 (−0.52–0.33)
Female 4984.87 (3625.16–6146.25) 12023.19 (8176.39–15222.21) 4.5 (3.28–5.54) 3.86 (2.74–4.82) −0.56 (−0.62–0.49)
Male 5901.48 (4339.9–7200.45) 13238.57 (9605.88–16100.75) 7.38 (5.41–8.96) 6.46 (4.7–7.87) −0.48 (−0.6–0.36)
High–income North America Both 23253.37 (16965.09–28708.35) 30355.13 (21656.69–37839.02) 6.48 (4.73–7.98) 4.75 (3.43–5.9) −1.22 (−1.32–1.12)
Female 11604.68 (8455.78–14454.54) 14217.63 (10080.74–17920.27) 5.38 (3.88–6.68) 3.91 (2.78–4.9) −1.21 (−1.29–1.14)
Male 11648.69 (8549.76–14262.86) 16137.5 (11850.98–19927.56) 8.02 (5.89–9.84) 5.73 (4.21–7.07) −1.35 (−1.48–1.21)
North Africa and Middle East Both 4572.21 (3321.56–5752.11) 13092.2 (9312.48–16064.5) 2.89 (2.11–3.63) 3.3 (2.37–4.05) 0.6 (0.42–0.78)
Female 2152.74 (1571.19–2760.68) 5839.8 (4120.29–7268.11) 2.74 (1.99–3.49) 3.01 (2.13–3.74) 0.46 (0.28–0.64)
Male 2419.47 (1780.01–3158.08) 7252.39 (5189.19–8935.34) 3.04 (2.24–3.93) 3.59 (2.55–4.41) 0.72 (0.54–0.91)
Oceania Both 78.96 (58.06–99.49) 210.95 (155.18–275.36) 3.01 (2.22–3.78) 3.39 (2.55–4.34) 0.4 (0.33–0.47)
Female 35.42 (24.72–45.7) 93.98 (67.95–124.26) 2.79 (1.96–3.61) 3.12 (2.3–4.07) 0.37 (0.3–0.45)
Male 43.54 (31.54–57.77) 116.97 (86.44–152.95) 3.24 (2.35–4.26) 3.69 (2.77–4.79) 0.42 (0.36–0.49)
South Asia Both 9650.42 (7685.01–11679.28) 31191.38 (23747.6–38373.25) 1.96 (1.56–2.36) 2.44 (1.87–3) 0.64 (0.52–0.76)
Female 4436.53 (3358.92–5620.88) 15450.4 (11326.59–19639.2) 1.86 (1.4–2.36) 2.36 (1.74–2.98) 0.65 (0.51–0.8)
Male 5213.9 (4054.17–6642.62) 15740.98 (11619.01–19871.6) 2.05 (1.6–2.57) 2.53 (1.88–3.18) 0.66 (0.54–0.77)
Southeast Asia Both 9939.21 (8112.04–11648.9) 32376.27 (24768.93–40353.41) 4.16 (3.41–4.86) 5.7 (4.37–7.08) 1 (0.94–1.06)
Female 4842.1 (3876.51–5836.05) 14237.49 (10375.15–18142.7) 3.8 (3.05–4.54) 4.63 (3.41–5.85) 0.59 (0.52–0.67)
Male 5097.12 (4156.31–6108.26) 18138.78 (14052.84–22556.32) 4.59 (3.76–5.5) 6.99 (5.36–8.65) 1.38 (1.32–1.44)
Southern Latin America Both 3568.63 (2756.86–4195.37) 6818.04 (5126.41–8143.82) 8.07 (6.23–9.47) 8.07 (6.06–9.62) 0.03 (−0.04–0.11)
Female 1685.54 (1280.62–1990.43) 3226.9 (2354.38–3897.67) 6.72 (5.12–7.96) 6.54 (4.8–7.9) −0.09 (−0.17–−0.01)
Male 1883.09 (1471.05–2207.64) 3591.13 (2738.95–4268.26) 9.8 (7.62–11.49) 10.06 (7.7–11.99) 0.16 (0.08–0.23)
Southern Sub–Saharan Africa Both 944.18 (734.47–1195.95) 2193.23 (1719.33–2668.29) 3.75 (2.89–4.8) 4.26 (3.35–5.17) 0.45 (0.22–0.67)
Female 480.66 (370.4–617.37) 1083.67 (835.48–1345.15) 3.34 (2.54–4.35) 3.58 (2.76–4.42) 0.35 (0.2–0.5)
Male 463.52 (356.34–609.34) 1109.56 (865.85–1344.46) 4.25 (3.26–5.66) 5.27 (4.14–6.35) 0.66 (0.35–0.98)
Tropical Latin America Both 2908.3 (2215.58–3504.74) 8983.97 (6692.65–11033.7) 3.49 (2.67–4.21) 3.78 (2.81–4.64) 0.31 (0.15–0.47)
Female 1493.87 (1122.91–1806.85) 4379.91 (3161.21–5467.68) 3.36 (2.52–4.07) 3.3 (2.38–4.12) −0.04 (−0.21–0.13)
Male 1414.43 (1092.19–1690.93) 4604.06 (3412.15–5624.17) 3.64 (2.83–4.36) 4.38 (3.25–5.35) 0.71 (0.56–0.87)
Western Europe Both 43390.97 (31730.84–52970.92) 56340.66 (40795.02–69276.86) 7.38 (5.41–9) 5.67 (4.09–6.95) −1.11 (−1.26–0.96)
Female 22020.89 (15888.11–27183.95) 25824.56 (18109.06–32340.04) 6.1 (4.42–7.51) 4.39 (3.13–5.45) −1.37 (−1.54–1.2)
Male 21370.09 (15872.37–25925.75) 30516.1 (22348.23–37299.29) 9.32 (6.94–11.29) 7.29 (5.34–8.9) −1.02 (−1.16–0.89)
Western Sub–Saharan Africa Both 2091.83 (1606.17–2643.13) 5181.18 (4002.21–6336.71) 2.69 (2.08–3.38) 3.2 (2.49–3.88) 0.77 (0.68–0.87)
Female 959.73 (712.33–1284.74) 2476.29 (1865.1–3144.12) 2.47 (1.84–3.27) 2.97 (2.28–3.7) 0.83 (0.72–0.95)
Male 1132.1 (846.76–1497.42) 2704.88 (2039.12–3428.87) 2.89 (2.19–3.76) 3.44 (2.62–4.32) 0.75 (0.67–0.84)

ASDR, age–standardized death rate; EAPC, estimated annual percentage change; UI, uncertainty interval.

Table 3.

DALYs, ASRs, and change trends of colorectal cancer attributable to dietary risks by SDI, regions, and sex.

Location Sex DALYs (No. × 1000, 95% UI) Age-standardized DALY rate (95% UI) EAPC (95% CI)
1990 2019 1990 2019 1990–2019
Global Both 4300.02 (3337–5083.52) 8210.62 (6142.38–9952.59) 107.18 (83.19–126.83) 99.79 (74.65–121.14) −0.28 (−0.35–0.22)
Female 2015.83 (1543.99–2396.6) 3397 (2529.89–4119.78) 94.3 (72.01–112.15) 78.21 (58.27–94.84) −0.76 (−0.82–0.71)
Male 2284.18 (1766.05–2689.63) 4813.62 (3570.52–5803.1) 122.68 (94.83–144.95) 123.94 (91.94–149.22) 0.06 (−0.02–0.14)
Sociodemographic Index
High SDI Both 1510.19 (1109.33–1853.36) 1993.88 (1452.5–2433.47) 147.35 (108.3–180.75) 112.54 (82.48–136.67) −1.04 (−1.09–1)
Female 693.58 (507.27–855.42) 838.99 (610.16–1029.99) 119.27 (87.22–146.74) 87.34 (63.87–106.59) −1.19 (−1.25–1.14)
Male 816.61 (604.37–989.71) 1154.9 (845.41–1403.71) 183.8 (136.26–222.79) 140.72 (103.32–170.88) −1.03 (−1.07–0.99)
High–middle SDI Both 1388.37 (1047.13–1646.78) 2371.04 (1719.22–2905.27) 127.88 (96.36–151.85) 117.55 (85.31–143.99) −0.44 (−0.55–0.33)
Female 665.93 (500.05–797.97) 954.08 (678.38–1182.94) 110.75 (83.11–132.6) 87.25 (62.38–108.16) −1.07 (−1.18–0.95)
Male 722.45 (549.12–855.24) 1416.96 (1022.2–1747.8) 151.1 (114.59–178.77) 153.66 (110.9–189.22) −0.01 (−0.14–0.12)
Low SDI Both 145.87 (114.56–180.29) 349.92 (273.14–415.11) 57.24 (44.86–70.5) 62.75 (49.32–74.54) 0.3 (0.26–0.35)
Female 66.24 (49.05–88.18) 165.46 (128.74–197.28) 51.96 (38.51–68.61) 58.01 (45.22–68.98) 0.37 (0.3–0.43)
Male 79.63 (60.82–105.86) 184.46 (142.06–223.66) 62.28 (47.63–82.1) 67.71 (52.37–81.99) 0.28 (0.25–0.31)
Low–middle SDI Both 373.4 (300.94–445.74) 1023.64 (783.53–1227.13) 57.84 (46.62–68.98) 72.18 (55.33–86.37) 0.77 (0.73–0.82)
Female 179.3 (141.11–220.27) 475.67 (363.22–582.54) 56.03 (44.29–68.51) 64.94 (49.91–79.37) 0.45 (0.38–0.52)
Male 194.11 (155.81–244.32) 547.97 (417.35–661.11) 59.62 (47.38–74.55) 80.01 (61.08–96.16) 1.09 (1.01–1.16)
Middle SDI Both 879.98 (714.9–1027.6) 2467.6 (1902.01–3001.62) 78.82 (64.06–91.75) 96.3 (74.09–116.96) 0.88 (0.74–1.02)
Female 409.73 (326.53–483.31) 960.78 (736.77–1185.61) 72.71 (58.19–85.74) 72.82 (55.79–89.62) 0.06 (−0.02–0.14)
Male 470.25 (380.43–559.15) 1506.82 (1152.36–1838.08) 85.32 (69.17–101.1) 121.61 (93.07–148.49) 1.52 (1.32–1.71)
Region
Africa Both 188.5 (149.57–227.64) 461.56 (351.92–556.8) 62.1 (49.23–74.63) 68.64 (53.06–82.09) 0.36 (0.32–0.41)
Female 86.76 (67.76–108.61) 212.53 (159.88–261.18) 56.68 (44.25–70.47) 61.48 (46.91–74.94) 0.34 (0.28–0.41)
Male 101.74 (80.05–127.17) 249.03 (187.29–301.34) 67.49 (53.43–83.71) 76.25 (57.82–91.72) 0.4 (0.36–0.44)
America Both 723.73 (543.48–878.44) 1241.73 (913.82–1510.25) 118.39 (88.96–143.81) 99.28 (73.05–120.71) −0.64 (−0.69–0.58)
Female 341.58 (252.74–418.03) 557.56 (404.27–683.88) 101.51 (75.28–124.16) 82.83 (60.1–101.41) −0.72 (−0.76–0.67)
Male 382.15 (287.81–460.02) 684.16 (509.18–829.26) 138.8 (104.63–167.4) 118.03 (87.83–143) −0.61 (−0.68–0.53)
Asia Both 1807.62 (1438.03–2116.73) 4661.07 (3513.52–5655.77) 84.2 (67.01–98.4) 95.8 (72.21–116.44) 0.58 (0.45–0.71)
Female 821.87 (647.66–978.66) 1832.46 (1401.52–2247.23) 75.79 (59.65–90.5) 73.23 (55.94–89.73) −0.12 (−0.2–0.05)
Male 985.75 (775.79–1171.5) 2828.6 (2129.59–3457.95) 93.42 (73.41–110.84) 120.11 (90.04–146.93) 1.11 (0.93–1.28)
Europe Both 1574.14 (1158.52–1906.23) 1834.29 (1298.71–2249.41) 153.82 (113.23–186.2) 124.47 (88.72–152.48) −1.04 (−1.17–0.9)
Female 762.94 (562.83–930.53) 789.36 (551.35–978.4) 127.83 (94.48–155.95) 95.09 (67.1–117.65) −1.36 (−1.49–1.23)
Male 811.2 (605.03–976.2) 1044.94 (760.88–1284.06) 191.89 (143.01–230.89) 161.46 (117.94–198.16) −0.87 (−1.01–0.74)
Andean Latin America Both 13.7 (10.77–16.47) 41.66 (29.44–54.4) 63.95 (50.53–76.83) 73.43 (51.99–95.52) 0.62 (0.48–0.76)
Female 7.08 (5.49–8.58) 21.1 (14.85–27.38) 64.8 (50.63–78.51) 71.82 (50.57–92.93) 0.37 (0.23–0.51)
Male 6.62 (5.21–8.03) 20.56 (14.6–27.28) 62.96 (49.44–76.8) 74.99 (53.33–99.82) 0.89 (0.73–1.05)
Australasia Both 44.17 (33.13–53.29) 58.12 (43.58–70.89) 191.45 (143.87–231.16) 124.26 (93.49–151.64) −1.8 (−1.93–1.67)
Female 19.88 (14.81–24.17) 25.31 (18.83–30.96) 160.66 (120.29–195.65) 102.27 (76.57–124.6) −1.81 (−1.91–1.7)
Male 24.29 (18.3–29.13) 32.81 (24.76–39.85) 228.04 (171.91–274.17) 148.31 (112.13–179.96) −1.84 (−1.99–1.69)
Caribbean Both 25.31 (18.75–30.25) 53.73 (37.36–68.8) 95.88 (70.97–114.52) 104.08 (72.44–133.26) 0.26 (0.18–0.33)
Female 12.69 (9.28–15.34) 25.67 (17.56–33.32) 93.07 (68.08–112.42) 93.88 (64.29–121.86) −0.02 (−0.08–0.04)
Male 12.62 (9.43–14.97) 28.06 (19.66–35.96) 98.75 (73.67–117.13) 115.18 (80.89–147.56) 0.53 (0.43–0.62)
Central Asia Both 54 (40.57–64.28) 69.67 (51.26–84.44) 107.98 (80.98–128.78) 89.35 (65.49–108.11) −0.68 (−0.8–0.55)
Female 25.85 (19.16–31.07) 32.05 (23.04–39.14) 92.04 (68.25–110.64) 74.8 (53.94–90.95) −0.77 (−0.87–0.68)
Male 28.15 (21.22–33.3) 37.62 (27.59–45.69) 129.59 (97.59–153.46) 108.24 (78.42–131.09) −0.61 (−0.78–0.44)
Central Europe Both 221.25 (155.24–273.77) 320.19 (217.45–405.66) 150.2 (105.71–185.55) 156.18 (107.13–197.77) 0.15 (0.05–0.26)
Female 97.96 (68.04–122.22) 125.07 (84.33–161.98) 119.08 (82.83–148.49) 109.27 (74.04–141.75) −0.33 (−0.42–0.25)
Male 123.29 (88.26–152.66) 195.12 (133.37–249.52) 190.77 (136.42–235.75) 215.28 (146.9–274.8) 0.48 (0.35–0.61)
Central Latin America Both 47.63 (36.39–57.08) 166.02 (116.31–213.99) 53.37 (40.88–64.02) 68.95 (48.41–88.73) 0.88 (0.83–0.93)
Female 24.22 (18.3–29.32) 76.57 (53.41–99.78) 53.04 (39.97–64.43) 59.47 (41.53–77.48) 0.41 (0.35–0.48)
Male 23.41 (18.09–27.77) 89.46 (63.16–115.17) 53.66 (41.58–63.55) 79.72 (56.41–102.34) 1.34 (1.28–1.4)
Central Sub–Saharan Africa Both 16.69 (12.48–21.57) 39.32 (28.16–52.12) 67.95 (51.59–87.36) 67.05 (48.71–89.1) −0.13 (−0.34–0.09)
Female 7.42 (5.23–10.14) 17.98 (12.82–24.81) 56.83 (41.22–76.12) 57.18 (40.85–79.37) −0.02 (−0.19–0.16)
Male 9.27 (6.81–12.83) 21.34 (14.58–32.03) 80.51 (59.53–111.03) 79.55 (55.42–121.94) −0.17 (−0.4–0.07)
East Asia Both 873.36 (678.24–1041.45) 2346.39 (1700.99–2967.47) 92.25 (71.83–109.96) 112.83 (82.05–142.19) 1.08 (0.82–1.34)
Female 391.37 (298.29–486.06) 801.34 (562.65–1043) 82.18 (62.79–102.03) 74.88 (52.67–97.45) −0.19 (−0.36–0.02)
Male 481.98 (366.84–598.24) 1545.05 (1098.63–2028.69) 104.23 (79.74–129.38) 154.74 (110.51–201.96) 1.92 (1.6–2.24)
Eastern Europe Both 443 (327.45–534.45) 441.29 (309.5–560.46) 157.39 (116.55–189.97) 131.46 (92.13–166.79) −1.3 (−1.6–1)
Female 238.3 (174.62–289.34) 213.48 (143.59–277.78) 136.73 (100.59–166.19) 105.06 (70.35–136.65) −1.59 (−1.86–1.31)
Male 204.7 (153.37–245.81) 227.8 (158.46–293.4) 196.73 (147.81–237.01) 172.95 (120.15–220.57) −1.12 (−1.44–0.8)
Eastern Sub–Saharan Africa Both 52.92 (41.08–66.17) 128.27 (96.42–159.97) 64.24 (50.33–79.83) 70.96 (53.6–87.96) 0.33 (0.26–0.4)
Female 24.34 (17.4–32.86) 59.33 (44.27–75.18) 57.26 (41.22–76.19) 62.77 (47.22–78.73) 0.3 (0.21–0.39)
Male 28.58 (21.49–39.61) 68.94 (50.7–89.98) 71.28 (53.58–97.37) 80.01 (59.15–104.08) 0.39 (0.34–0.45)
High–income Asia Pacific Both 255.21 (185.36–314.74) 438.82 (320.95–537.6) 125.9 (91.41–155.07) 107.52 (79.04–131.26) −0.59 (−0.7–0.47)
Female 109.74 (79.25–136.56) 182.52 (131.21–226.96) 98.27 (71.02–122.32) 79.78 (58.36–98.12) −0.78 (−0.87–0.7)
Male 145.47 (106.53–178.12) 256.3 (187.81–312.13) 161.59 (118.17–197.6) 138.47 (101.99–168.63) −0.57 (−0.7–0.43)
High–income North America Both 488.08 (357.16–598.6) 634.9 (456.84–783.79) 142.64 (104.97–174.69) 108.82 (78.24–133.86) −1.03 (−1.13–0.93)
Female 227.12 (164–280.55) 275.49 (197.5–344.57) 117.03 (85.56–143.91) 88 (62.68–109.2) −1.06 (−1.14–0.98)
Male 260.97 (191.73–318.76) 359.41 (261.95–442.15) 175.41 (128.59–214.29) 132.13 (96.4–162.06) −1.1 (−1.23–0.98)
North Africa and Middle East Both 124.72 (91.55–157.94) 334.99 (235.71–413.49) 67.26 (49.09–84.95) 72.57 (51.33–89.26) 0.35 (0.17–0.53)
Female 58.09 (41.87–75.39) 146.56 (102.18–182.58) 63.59 (46.04–81.94) 65.16 (45.86–80.95) 0.16 (0.01–0.32)
Male 66.64 (48.53–87.69) 188.42 (132.1–233.31) 70.77 (51.69–92.56) 79.71 (56.79–98.44) 0.5 (0.31–0.7)
Oceania Both 2.32 (1.68–2.95) 6.13 (4.49–8.14) 69.86 (51.48–88) 77.68 (57.07–101.22) 0.35 (0.3–0.41)
Female 1.02 (0.71–1.31) 2.66 (1.88–3.59) 64 (44.68–82.59) 70.41 (50.81–93.45) 0.33 (0.26–0.4)
Male 1.3 (0.93–1.74) 3.47 (2.53–4.61) 75.52 (54.86–99.85) 84.7 (62.59–110.71) 0.38 (0.32–0.43)
South Asia Both 266.57 (210.7–322.12) 766.17 (572.31–947.95) 44.1 (35.07–53.26) 53.08 (40.06–65.54) 0.54 (0.44–0.65)
Female 125.57 (94.36–159.35) 377.88 (272.91–482.79) 42.89 (32.33–54.36) 51.62 (37.34–65.73) 0.5 (0.36–0.65)
Male 141.01 (109.36–180.46) 388.28 (283.57–487.76) 45.25 (35.25–57.57) 54.63 (40.05–68.51) 0.59 (0.49–0.69)
Southeast Asia Both 277.37 (226.11–327.3) 837.95 (643.88–1045.17) 98.89 (80.66–115.91) 130.74 (100.31–162.77) 0.87 (0.8–0.94)
Female 132.13 (103.47–161.49) 349.11 (255.34–448.3) 89.67 (70.88–108.73) 103.55 (75.31–132.57) 0.4 (0.32–0.48)
Male 145.24 (118.77–174.72) 488.85 (377.81–607.63) 109.32 (89.05–131.1) 161.8 (125.53–200.71) 1.27 (1.21–1.33)
Southern Latin America Both 78.61 (60.88–92.39) 139.37 (104.3–166.42) 170.1 (131.68–200) 170.06 (127.4–202.99) 0.06 (0.01–0.12)
Female 35.1 (26.78–41.73) 61.44 (45.12–74.44) 138.23 (105.45–164.12) 135.11 (99.7–163.53) −0.02 (−0.08–0.04)
Male 43.51 (34.07–50.93) 77.93 (59.1–93.1) 209.02 (163.33–244.67) 212.62 (161.73–254.05) 0.12 (0.06–0.19)
Southern Sub–Saharan Africa Both 23.87 (18.87–29.31) 54.64 (42.58–66.72) 81.73 (63.95–102.59) 92.62 (72.61–113.46) 0.51 (0.28–0.74)
Female 11.24 (8.91–13.86) 24.95 (19.07–31.35) 69.66 (54.64–87.27) 75.09 (57.41–94.56) 0.53 (0.38–0.69)
Male 12.63 (9.82–16.19) 29.69 (22.93–36.28) 96.34 (74.3–125.56) 116.13 (90.29–141.17) 0.58 (0.24–0.91)
Tropical Latin America Both 75.02 (56.88–90.54) 215.15 (158.74–264.19) 77.47 (58.91–93.63) 87.22 (64.43–106.99) 0.45 (0.26–0.64)
Female 37.42 (28.08–45.49) 101.2 (73.41–125.42) 73.49 (55.05–89.15) 75.84 (55.08–94.02) 0.15 (−0.04–0.34)
Male 37.59 (29.02–44.84) 113.95 (84.75–139.21) 81.83 (63.12–97.61) 100.79 (74.92–123.48) 0.77 (0.58–0.96)
Western Europe Both 863.71 (636.17–1051.3) 987.94 (717.78–1211.32) 154.04 (113.72–187.21) 115.62 (85.26–141.28) −1.19 (−1.31–1.07)
Female 406.27 (297.3–497.84) 416.42 (295.08–513.64) 125.72 (92.73–153.54) 88.51 (63.28–108.28) −1.43 (−1.54–1.31)
Male 457.44 (340.94–554.48) 571.52 (422.65–697.33) 192.16 (143.24–232.73) 147.05 (108.72–179.45) −1.11 (−1.24–0.99)
Western Sub–Saharan Africa Both 52.52 (39.99–66.88) 129.92 (99.06–161.19) 57.94 (44.31–73.44) 66.23 (51.23–81.5) 0.6 (0.51–0.69)
Female 23.03 (17.08–31.21) 60.87 (44.86–79.64) 52.19 (38.67–70.26) 59.96 (45.01–76.94) 0.65 (0.53–0.77)
Male 29.49 (21.84–39.18) 69.05 (51.8–88.15) 63.27 (47.35–83.37) 73.04 (54.79–92.42) 0.62 (0.54–0.7)

DALYs, disability–adjusted life years; EAPC, estimated annual percentage change; SDI, socio–demographic index; UI, uncertainty interval.

Deaths and DALYs of colorectal cancer due to dietary risks increased by 50.88 and 47.63%, respectively. Women accounted for 41.37 and 44.13% of colorectal cancer deaths and DALYs due to dietary risks, with 58.63% and 55.87% for men (Tables 2, 3). Men had higher death and DALY rates than women at all ages, and the gap widened with age (Figure 1 and Supplementary Figure 2). Both age-standardized death rate (ASDR) and age-standardized DALY rate were higher among men (with a stable trend) than among women (with a declining trend). As for risk factors, low-whole grain diets remained the leading cause of colorectal cancer death and DALY rate over time, followed by milk and calcium (Supplementary Figure 3). Whole grains, milk, and calcium accounted for 81.61% of deaths and 81.64% of DALYs for dietary risk factors related to the colorectal cancer burden globally (Supplementary Table 8). The leading cause of colorectal cancer death and DALY rate was low whole grains in America and Europe, low milk in Asia, and low calcium in Africa (Supplementary Figure 4). The ASDR and age-standardized DALY rates of four risk factors related to colorectal cancer decreased in several factors (including grains, fiber, red meat, and processed meat, Supplementary Tables 916); increased in one (milk, Supplementary Tables 17, 18); and kept one stable (calcium, Supplementary Tables 19, 20). Alarmingly, diets high in red meat were related to the increase in ASDR of colorectal cancer among men (EAPC = 0.07, 95% CI: 0.01–0.12, Supplementary Table 13). The ASDR of low whole grains was attributable to decreased colorectal cancer among women (EAPC = −0.7, 95% CI: −0.78 to 0.62) but was stable among men (EAPC = 0.02, 95% CI: −0.05 to 0.1, Supplementary Table 8). The ASDR of colorectal cancer due to diets low in milk and calcium decreased among women (milk: EAPC = −0.19, 95% CI: −0.23 to 0.15, Supplementary Table 17; calcium: EAPC = −0.35, 95% CI: −0.42 to 0.28, Supplementary Table 19) but increased among men (milk: EAPC = 0.48, 95% CI: 0.43–0.54; calcium: EAPC = 0.27, 95% CI: 0.15–0.39). The three leading dietary risk factors of the DALY rate were whole grains, milk, and red meat; for the death rate, they were whole grains, milk, and calcium among all age groups and genders (Figure 2).

Figure 1.

Figure 1

The death rate of six dietary risk factors related to colorectal cancer among four world regions in 2019. The vertical axis is the death rate (per 100,000 persons). The horizontal axis represents different age groups.

Figure 2.

Figure 2

The death and disability-adjusted life-years (DALY) rate of six dietary risk factors related to colorectal cancer among various age groups. The upper column in each group represents data in 2019, and the lower column in each group represents data in 1990. The vertical axis is the death or DALY rate (per 100,000 persons). The horizontal axis represents different age groups. (A) Both genders, (B) women, and (C) men.

Attributable Burden by Socio-Demographic Index

High-middle and middle SDI quintiles have always carried the highest deaths of colorectal cancer attributable to dietary risks (Table 2). The district with the highest DALYs changed from high SDI in 1990 into middle SDI in 2019 (Table 3). The ASDR and age-standardized DALY rates showed an upward trend in the middle, low-middle, and low SDI quintiles and increased the fastest in the middle SDI quintile (ASDR: EAPC = 0.96, 95% CI: 0.81–1.11; DALY: EAPC = 0.88, 95% CI: 0.74–1.02, Figure 3). In contrast, ASDR and age-standardized DALY rates declined the fastest in the high SDI quintile (ASDR: EAPC = −1.04, 95% CI: −1.11 to 0.98; DALY: EAPC = −1.04, 95% CI: −1.09 to 1). For men, ASDR and age-standardized DALY rates increased in all SDI quintiles, except for the high SDI quintile (ASDR: EAPC = −1.06, 95% CI: −1.11 to 1.01; DALY: EAPC = −1.03, 95% CI: −1.07 to 0.99). The ASDR and age-standardized DALY rates among regions increased first and then decreased with an increase in SDI value, with the inflection point being 0.75 (Figure 4).

Figure 3.

Figure 3

The age-standardized rates (ASRs) for dietary risk-related colorectal cancer among socio-demographic index (SDI) quintiles over the last 30 years. (A) Both genders, (B) women, and (C) men. ASDR, age-standardized death rate; DALY, disability-adjusted life-year; SDI, socio-demographic index.

Figure 4.

Figure 4

The ASRs of dietary risk related colorectal cancer among 21 regions based on SDI in 2019. The vertical axis is the age-standardized death and DALY rate (per 100,000 person-years), and the horizontal axis is the SDI value in 2019. Each combination of colors and shapes represents a region. Each point represents the age-standardized death and DALY rate (per 100,000 person-years) that year in each region. Each combination of the same color and shape, from front to back, represents the data for each year from 1990 to 2019. (A) ASDR or age-standardized DALY rate for both genders; (B) ASDR or age-standardized DALY rate for women; and (C) ASDR or age-standardized DALY rate for men. ASDR, age-standardized death rate; DALY, disability-adjusted life-year; SDI, socio-demographic index.

Regional Attributable Burden

Asia carried the highest colorectal cancer DALYs attributable to dietary risks (accounting for almost half of the world) for over 30 years, especially for East Asia (accounting for almost half of Asia, Table 3). The region with the highest deaths changed from Europe (particularly in Western Europe) in 1990 to Asia (particularly in East Asia) in 2019 (Table 2). On the other hand, Europe has always had the highest ASDR and age-standardized DALY rate with the fastest decreasing rate (ASDR: EAPC = −0.88, 95% CI: −1.03 to 0.74; DALY: EAPC = −1.04, 95% CI: −1.17 to 0.9, Figure 5), while Africa always had the lowest. From 1990 to 2019, both ASDR and age-standardized DALY rate increased the fastest in Asia (ASDR: EAPC = 0.69, 95% CI: 0.5–0.83; DALY: EAPC = 0.58, 95% CI: 0.45−0.71), particularly in East Asia. However, the age-standardized DALY rate showed a downward trend for women in East Asia (EAPC = −0.19, 95% CI: −0.36 to 0.02).

Figure 5.

Figure 5

The estimated annual percentage changes (EAPCs) of age-standardized death and DALY rate for dietary risk related colorectal cancer. (A) EAPCs of ASDR (per 100,000 population); (B) EAPCs of age-standardized DALY rate (per 100,000 population). EAPC, estimated annual percentage changes; DALY, disability-adjusted life-year.

Attributable Burden by Countries and Territories

China always had the highest deaths (29,656 in 1990 and 90,407 in 2019) and DALY (834,715.34 in 1990 and 2,234,062.97 in 2019) of colorectal cancer attributable to dietary risks, followed by the USA, India, and Japan. From 1990 to 2019, the country with the highest ASDR and age-standardized DALY rate changed from Uruguay (ASDR: 10.91, 95% UI: 8.31–12.95; DALY: 230.92, 95% UI: 175.88–275.31) to Greenland (ASDR: 9.78, 95% UI: 6.83–12.82; DALY: 213.43, 95% UI: 145.89–281.33). The ASDR increased the fastest in Equatorial Guinea (EAPC = 2.62, 95% CI: 2.422.81, Supplementary Table 21), and the age-standardized DALY rate increased the fastest in Lesotho (EAPC = 2.6, 95%CI: 2.37–2.83, Supplementary Table 22) but decreased the fastest in Austria. All the countries and territories among the regions are shown in Supplementary Table 23.

Discussion

This analysis comprehensively investigated the latest data on dietary risk factors related to colorectal cancer burden. Deaths and DALYs of colorectal cancer grew by 50.88 and 47.63% over the last 30 years. Dietary risk factors pose a greater global burden than smoking or drinking (10), highlighting the urgency of improving diets across regions and countries. The burden of colorectal cancer due to dietary factors differs between men and women. Compared with women, men tend to eat less healthily. Thus, this difference should be considered in the prevention programs of national policymakers. Though the effect of dietary factors varied across regions and countries, three dietary factors (diets low in whole grains, milk, and calcium) accounted for more than four-fifths of the colorectal cancer burden attributable to diet, mirroring the global imbalance of nutrition, which is consistent with the previous study (11). Dietary modifications are an effective strategy to reduce the colorectal cancer burden. Though dietary interventions have been identified, the observed effects of most of these measures fall far short of what is required for an optimal global diet (12).

Obesity is related to the occurrence of colorectal cancer (13). However, balanced nutrition diets can regulate physique and improve obesity. Our findings suggest that people should attach importance to nutritionally balanced diets and not just the restriction of sugar (14) and fat (15, 16).

Alarmingly, there was a significant upward trend in the rate of people exposed to low milk, which reminds the government to take measures, such as scientific education and interventions, to stimulate the production, supply, and consumption of healthy food (17). Previous studies indicated that milk and calcium intake significantly reduced the risk of colorectal cancer (18). It was found that milk intake varied widely from region to region. Interestingly, in high-income North America (Canada, Greenland, and the USA), dietary exposure was growing at a high speed. In Southeast Asia and Western and Central sub-Saharan Africa, people remained highly exposed to low milk intake. In contrast, milk intake in Eastern Europe, Australasia (Australia and New Zealand), Central Asia, and high-income North America improved considerably, especially in Australia. Studies have shown that milk intake plays a protective effect against colon cancer in people (19, 20). According to a research study, calcium, vitamin D, conjugated linoleic acid, butyric acid, and lactose in milk have certain anti-tumor effects (20). In addition, whole grains have the anti-cancer properties of fiber, antioxidants, and phytochemicals (21). It is worth noting that whole grain intakes are low in Central Asia compared to the high intakes of whole grains in Southeast Asia. It has been proven that high fiber intake is associated with better survival of patients with colorectal cancer (22), particularly in cereals (21).

The analysis also presented that the diets of people in Oceania and Western sub-Saharan Africa were rich in fiber, but the opposite was true for Southeast Asians and Southern Latin Americans (Argentina, Chile, and Uruguay). In addition, low calcium intake exposure was severe in Central sub-Saharan Africans and Southeast Asians. According to the published studies, calcium affects the progression of colorectal cancer by inhibiting cell proliferation and DNA oxidative damage. By extension, it promotes cell differentiation and apoptosis and regulates the cell signaling pathways associated with colorectal cancer (4).

In line with this, there is much room for improvement in public management policies (16), community programs, and primary healthcare interventions on dietary risks to have a greater impact on disease outcomes (23).

Calcium, fiber, milk, and whole grains were associated with a lower risk of colorectal cancer, while red and processed meats were correlated with an increase in this risk (4). Effective prevention programs and appropriate strategies, such as limiting junk food advertising, raising taxes on unhealthy foods, offering subsidies for the consumption of healthy foods, and providing supply chain incentives to promote production, are necessary to reduce the dietary risk factors in populations (23). It was observed that high red meat (especially for men) consumption in patients with colorectal cancer increased over the last 30 years. There was a high intake of red meat in Australia and Southern Latin America (Argentina, Chile, and Uruguay), while this intake was the lowest in South Asia (Bangladesh, Bhutan, India, Nepal, and Pakistan). Red meat consumption increased the fastest in East Asia (China and North Korea), which should be taken seriously. As for processed meat, consumption remained high among high-income North Americans and Western Europeans. Processed meat consumption increased globally, particularly in East Asia, Tropical Latin America (Brazil and Paraguay), and Southeast Asia. Heme iron, N-nitro compounds, and heterocyclic amines found in red and processed meats can produce carcinogens when cooked at high temperatures (24). Governments should strengthen assessments based on the life-circle (25) and carry out targeted prevention programs across nations, which is a strategy that is more environmentally sustainable (26).

Without health-related measure values, SDI was found to be a better way to assess the impact of health risk factors (27) than health-related human development indices (28). Deaths and DALYs of dietary factor-related colorectal cancer increased globally, particularly in the high-middle and middle SDI quintiles, and continued to decline in the high SDI quintile. This might have been due to the benefits of balanced diets and the huge improvements in diagnostics and interventions in this quintile.

Similarly, low socioeconomic status was associated with a higher risk of colorectal cancer (7). Our study demonstrated the gaps in regional and national colorectal cancer data on nutrient intake worldwide, suggesting the necessity of national surveillance systems for key dietary factors (29). Asia accounted for almost half of this burden worldwide, particularly in East Asia, which had the fastest increasing rate (30). Thus, it is essential for Chinese women and Hungarian men to cultivate a balanced diet to reduce their high dietary risk exposure (31). Countries should also use innovative technologies to strengthen their distinctive policy programs for the improvement of diet sustainability (32).

Some limitations were inevitable in this study. First, part of the variation in the age-standardized rates might have resulted from test biases or changes in screening regimens. In addition, many underdeveloped countries lack detailed data for further investigation. Though various data sources such as cancer registries and vital registries were used for cancer estimates, estimates for countries with no relevant information were dependent on predictive covariates or trends in neighboring countries.

The joint assessment of multiple dietary risk factors is important for the establishment of public policy. In addition, more detailed dietary surveys are needed to strengthen the accuracy and reliability of the conclusions. Further research studies on dietary factors are required to expand and deepen the understanding of dietary risk factors related to colorectal cancer and improve its detection, treatment, and prognosis.

In conclusion, dietary risk factors affected the burden of colorectal patients regardless of age. In addition, there were large variations of dietary risks related to the colorectal cancer burden among sexes, regions, and countries. The ASDR and age-standardized DALY rate presented downward trends globally, especially in the high SDI quintile. All ASRs remained higher among men (stable) than in women (decline) over the measurement periods, indicating that men need more diet control than women. Lastly, the findings could provide valuable information for policymakers to target interventions and address modifiable risk factors and for researchers to design and conduct studies on the early diagnosis and treatment of colorectal cancer and a balanced diet.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The studies involving human participants were reviewed and approved by The First Affiliated Hospital, College of Medicine, Zhejiang University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

All authors read, critically reviewed, and approved the final manuscript. ZD and JL designed the research. YD, BW, and ZZ collected the data. YZ, JY, and SW verified the accuracy of the data. DX, JH, XY, and SY contributed to the data interpretation. YD, YW, NL, and PX performed the statistical analysis and visualization. YD wrote the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank all the members of our study team for their wonderful cooperation and the Global Burden of Disease Study for their works.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2021.690663/full#supplementary-material

References

  • 1.Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. (2020) 396:1204–22. 10.1016/S0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. (2020) 396:1223–49. 10.1016/S0140-6736(20)30752-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. (2020) 158:322–40. 10.1053/j.gastro.2019.06.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. (2015) 148:1244–60.e16. 10.1053/j.gastro.2014.12.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Cancer Research Fund International/American Institute for Cancer Research . Continuous update project report: Diet, nutrition, physical activity, and colorectal cancer, American Institute for Cancer Research, (2018).
  • 6.Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. (2019) 16:713–32. 10.1038/s41575-019-0189-8 [DOI] [PubMed] [Google Scholar]
  • 7.Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. (2019) 11:164. 10.3390/nu11010164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yang J, Li Y, Liu Q, Li L, Feng A, Wang T., et al. Brief introduction of medical database and data mining technology in big data era. J Evid Based Med. (2020) 13:57–69. 10.1111/jebm.12373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Deng Y, Zhao P, Zhou L, Xiang D, Hu J, Liu Y., et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. J Hematol Oncol. (2020) 13:98. 10.1186/s13045-020-00915-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Global, regional, and national comparative risk assessment of 79 behavioural environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. (2016) 388:1659–724. 10.1016/S0140-6736(16)31679-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Health effects of dietary risks in 195 countries 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2019) 393:1958–72. 10.1016/S0140-6736(19)30041-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Afshin A, Penalvo J, Del Gobbo L, Kashaf M, Micha R, Morrish KJ, et al. CVD Prevention through policy: a review of mass media, food/menu labeling, taxation/subsidies, built environment, school procurement, worksite wellness, and marketing standards to improve diet. Curr Cardiol Rep. (2015) 17:98. 10.1007/s11886-015-0658-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. (2013) 62:933–47. 10.1136/gutjnl-2013-304701 [DOI] [PubMed] [Google Scholar]
  • 14.Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. (2011) 378:31–40. 10.1016/S0140-6736(11)60679-X [DOI] [PubMed] [Google Scholar]
  • 15.Al-Mrabeh A, Zhyzhneuskaya SV, Peters C, Barnes AC, Melhem S, Jesuthasan A, et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metabolism. (2020) 31:233–49.e4. 10.1016/j.cmet.2019.11.018 [DOI] [PubMed] [Google Scholar]
  • 16.Downs SM, Thow AM, Leeder SR. The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence. Bull World Health Organ. (2013) 91:262–9h. 10.2471/BLT.12.111468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Anand SS, Hawkes C, Souza RJde, Mente A, Dehghan MR, Nugent MA, et al. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the world heart federation. J Am Coll Cardiol. (2015) 66:1590–614. 10.1016/j.jacc.2015.07.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kawada T. Milk intake and risk of colorectal cancer. Br J Nutr. (2019) 122:120. 10.1017/S000711451900059X [DOI] [PubMed] [Google Scholar]
  • 19.Larsson SC, Mason AM, Kar S, Vithayathil M, Carter P, Baron JAK, et al. Genetically proxied milk consumption and risk of colorectal, bladder, breast, and prostate cancer: a two-sample Mendelian randomization study. BMC Med. (2020) 18:370. 10.1186/s12916-020-01839-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Barrubés L, Babio N, Becerra-Tomás N, Rosique-Esteban N, Salas-Salvadó J. Association between dairy product consumption and colorectal cancer risk in adults: a systematic review and meta-analysis of epidemiologic studies. Adv Nutr. (2019) 10:S190–s211. 10.1093/advances/nmy114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E., et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. (2011) 343:d6617. 10.1136/bmj.d6617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Song M, Wu K, Meyerhardt JA, Ogino S, Wang M, Fuchs CS., et al. Fiber intake and survival after colorectal cancer diagnosis. JAMA oncology. (2018) 4:71–9. 10.1001/jamaoncol.2017.3684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hawkes C, Smith TG, Jewell J, Wardle J, Hammond RA, Friel S., et al. Smart food policies for obesity prevention. Lancet. (2015) 385:2410–21. 10.1016/S0140-6736(14)61745-1 [DOI] [PubMed] [Google Scholar]
  • 24.Deoula S. M, El Kinany K, Huybrechts I, Gunter MJ, Hatime Z, Boudouaya HA, et al. Consumption of meat, traditional and modern processed meat and colorectal cancer risk among the Moroccan population: a large-scale case-control study. Int J Cancer. (2020) 146:1333–45. 10.1002/ijc.32689 [DOI] [PubMed] [Google Scholar]
  • 25.Heller MC, Keoleian GA, Willett WC. Toward a life cycle-based, diet-level framework for food environmental impact and nutritional quality assessment: a critical review. Environ Sci Technol. (2013) 47:12632–47. 10.1021/es4025113 [DOI] [PubMed] [Google Scholar]
  • 26.Tilman D, Clark M. Global diets link environmental sustainability and human health. Nature. (2014) 515:518–22. 10.1038/nature13959 [DOI] [PubMed] [Google Scholar]
  • 27.The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. (2019) 4:913–33. 10.1016/S2468-1253(19)30345-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. (2017) 66:683–91. 10.1136/gutjnl-2015-310912 [DOI] [PubMed] [Google Scholar]
  • 29.Micha R, Khatibzadeh S, Shi P, Andrews KG, Engell RE, Mozaffarian D. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide. BMJ Open. (2015) 5:e008705. 10.1136/bmjopen-2015-008705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lachat C, Otchere S, Roberfroid D, Abdulai A, Seret FM, Milesevic J, et al. Diet and physical activity for the prevention of noncommunicable diseases in low- and middle-income countries: a systematic policy review. PLoS Med. (2013) 10:e1001465. 10.1371/journal.pmed.1001465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, et al. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Global health. (2017) 5:e277–89. 10.1016/S2214-109X(17)30058-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Illner AK, Freisling H, Boeing H, Huybrechts I, Crispim SP, Slimani N. Review and evaluation of innovative technologies for measuring diet in nutritional epidemiology. Int J Epidemiol. (2012) 41:1187–203. 10.1093/ije/dys105 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.


Articles from Frontiers in Nutrition are provided here courtesy of Frontiers Media SA

RESOURCES